PET scan using an integrin marker to find cancer
Part of Cancer, Lungs & breathing, Skin clinical trials.
This trial uses a special PET/CT scan that targets a protein on some cancer cells to help detect and evaluate malignant tumors. It may help doctors better map tumors before any cancer treatment starts.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- Your cancer is newly diagnosed and confirmed by biopsy/pathology, or the concern is lung cancer.
- You have not had any cancer treatment yet, like chemotherapy, radiation, targeted therapy, or immunotherapy.
- You must be able to do the scan and daily study steps (ECOG performance status 0–1, generally able to care for yourself).
- You can’t be pregnant or breastfeeding, and you must agree to reliable birth control during the study and for 6 months after it ends (if applicable).
- You are willing to sign consent and do not plan to stop the study early.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of PET scan that uses a special tracer to find lung tumors. The goal is to see if this scan can better detect cancer cells, which may help doctors plan the best treatment for you.
This study uses a special type of PET scan to look at specific cells in non-small cell lung cancer tumors that might help doctors understand how well immunotherapy treatments are working. If you are about to start immunotherapy for advanced lung cancer, you may be able to join.
This study tests a new type of imaging scan (PET/CT or PET/MR) that uses a radioactive tracer to help doctors better detect and diagnose various cancers. The scan targets a specific protein found in tumors, which may help identify cancer more accurately than standard imaging.
This study uses a special PET/CT scan that targets a protein called c-Met to help diagnose and stage non-small cell lung cancer. It aims to see if this imaging method can better identify tumor locations and characteristics.
This trial is testing a new radioactive imaging agent that targets a protein called Nectin-4, which is often found on lung tumors. The scan will help doctors see if the tumor is visible and how it spreads, which may guide better treatment decisions for lung cancer patients.
This trial uses a special PET scan to see how well your breast cancer is responding to neoadjuvant therapy (treatment given before surgery). The goal is to help doctors personalize your care by checking if the cancer is shrinking.
Hear when a new PET/CT trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.